Latest News about AVRO

Recent news which mentions AVRO

< Previous 1 2 Next >

PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML

June 20, 2024

Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?

June 20, 2024

Why Is Avrobio (AVRO) Stock Moving Today?

June 20, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

June 20, 2024

AVRO Stock Earnings: Avrobio Beats EPS for Q1 2024

May 13, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session

July 12, 2023

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

July 12, 2023

Why Avrobio Shares Are Rising Wednesday

July 12, 2023

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

July 12, 2023

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

June 07, 2023

Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis

May 22, 2023

Dow Tumbles 100 Points; Micron Technology Shares Plunge

May 22, 2023

12 Health Care Stocks Moving In Monday's Intraday Session

May 22, 2023

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

May 22, 2023

Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis

May 22, 2023

Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher

May 22, 2023

Why Is AVROBIO (AVRO) Stock Up 83% Today?

May 22, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session

May 22, 2023

Analyst Says Gene Therapy Data Update Offers Insights into Potential Pivotal Endpoints

May 18, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session

May 18, 2023

Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months

May 18, 2023

Recap: Avrobio Q1 Earnings

May 11, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session

March 23, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session

January 10, 2023

Avrobio Touts New Positive Data From Gaucher Disease Gene Therapy

December 07, 2022

AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2

December 07, 2022

Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment

November 29, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

September 20, 2022

Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions

September 20, 2022

Recap: Avrobio Q2 Earnings

August 09, 2022

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.